Post Intravitreal Injection Topical NSAID vs. Patching

• Status: Unknown status
• Trial end date: 2019-06-03
• Target enrollment: 0
• Participant gender: All

Summary

A prospective randomized trial, to evaluate post-injection comfort measures comparing topical NSAID (nepafenac 0.3% suspension) and patching.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The New York Eye & Ear Infirmary
• Treatments: Carboxymethylcellulose Sodium; Nepafenac

Criteria

Inclusion Criteria:

• 18 years of age or older

• Already scheduled for anti-VEGF injection based on standard of care for disease process.

• Ability to provide written informed consent

• Capable of complying with study protocol.

• Volunteer written informed consent with the understanding that consent may be withdrawn by the subject at any time without prejudice to future care

Exclusion Criteria:

• History of past intraocular injection of steroid medication.

• Experiencing baseline eye pain

• Monocular; non-study eye with VA<20/100.

• Unwilling or unable to follow or comply with all study related procedures